These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10499144)

  • 61. [Acute drug-induced agranulocytosis: experience of the Regional Center of Pharmacovigilance of Lyon over 7 years].
    Vial T; Pofilet C; Pham E; Payen C; Evreux JC
    Therapie; 1996; 51(5):508-15. PubMed ID: 9138385
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Interactions and adverse drug reactions: how to obtain information].
    Fattinger KE
    Praxis (Bern 1994); 1999 Apr; 88(16):713-8. PubMed ID: 10355337
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pharmacovigilance in pharmacy practice].
    Duquet N
    J Pharm Belg; 2011 Dec; (4):97-103. PubMed ID: 22299235
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An appraisal of spontaneous adverse event monitoring.
    Fletcher AP
    Adverse Drug React Toxicol Rev; 1992; 11(4):213-27. PubMed ID: 1489882
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Monitoring of NSAIDs adverse effects based on spontaneous reports from Wrocław regional adverse drug reactions monitoring center.
    Jaźwińska-Tarnawska E; Wiela-Hojeńska A; Wolańczyk-Medrala A; Patkowski J; Nittner-Marszalska M; Głowacka K
    Acta Pol Pharm; 2012; 69(5):979-84. PubMed ID: 23061296
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adverse reaction assessment in Thailand.
    Sriwatanakul K; Pothisiri P
    Med Toxicol; 1986; 1 Suppl 1():105-9. PubMed ID: 3821423
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Background noise in healthy volunteers--a consideration in adverse drug reaction studies.
    Khosla PP; Bajaj VK; Sharma G; Mishra KC
    Indian J Physiol Pharmacol; 1992 Oct; 36(4):259-62. PubMed ID: 1291478
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Reasons to report or not report side effects of drugs to the national monitoring system in the Netherlands].
    van Riemsdijk MM; Herings RM; Rawlins MD; Stricker BH
    Ned Tijdschr Geneeskd; 1995 Nov; 139(45):2306-8. PubMed ID: 7501063
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Pharmacovigilance seen by a selected group of general practitioners and of residents in the Midi-Pyrénées region].
    Pouget-Zago P; Lapeyre-Mestre M; Bagheri H; Montastruc JL
    Therapie; 1995; 50(5):459-62. PubMed ID: 8571286
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An evaluation of spontaneous adverse drug reaction monitoring systems.
    Sachs RM; Bortnichak EA
    Am J Med; 1986 Nov; 81(5B):49-55. PubMed ID: 3789003
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance].
    Imbs JL; Pouyanne P; Haramburu F; Welsch M; Decker N; Blayac JP; Bégaud B
    Therapie; 1999; 54(1):21-7. PubMed ID: 10216418
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Pharmacovigilance of antibiotics. Evaluation by the Midi-Pyrénées Pharmacovigilance Center between 1989 and 1992].
    Llau ME; Damase-Michel C; Lapeyre-Mestre M; Vie M; Rascol O
    Therapie; 1994; 49(2):123-7. PubMed ID: 7817335
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Drug induced fatal anaphylactic shock in Denmark 1968-1990].
    Lenler-Petersen P; Hansen D; Andersen M; Sørensen HT; Bille H
    Ugeskr Laeger; 1996 Jun; 158(23):3316-8. PubMed ID: 8686061
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Quality of drugs and adverse drug reactions.
    Maciejczyk A; Czarnecki A
    Acta Pol Pharm; 1997; 54(5):393-5. PubMed ID: 9584696
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Centre for Adverse Reactions Monitoring report for the year ending 30 June, 1993.
    Pillans PI; Coulter DM
    N Z Med J; 1994 Nov; 107(990):490-3. PubMed ID: 7970369
    [No Abstract]   [Full Text] [Related]  

  • 76. [Drug-induced discoloration of the teeth and gingiva].
    Mosimann P; Hartmann K; Kuhn M
    Praxis (Bern 1994); 1998 Mar; 87(12):413-6. PubMed ID: 9564238
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Welsh Adverse Drug Reactions Scheme: experience of a UK regional monitoring centre.
    Houghton JE; Pinto Pereira LM; Woods FJ; Richens A; Routledge PA
    Adverse Drug React Toxicol Rev; 1996 Jun; 15(2):93-107. PubMed ID: 8836315
    [No Abstract]   [Full Text] [Related]  

  • 78. Adverse drug reactions.
    O'Donnell J
    Leg Med; 1994; ():229-67. PubMed ID: 7830481
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions.
    Macedo AF; Alves C; Craveiro N; Marques FB
    J Nurs Manag; 2011 Apr; 19(3):395-9. PubMed ID: 21507111
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Associations of gender and age with the reporting of drug-induced hepatic failure: data from the VigiBase™.
    Petronijevic M; Ilic K
    J Clin Pharmacol; 2013 Apr; 53(4):435-43. PubMed ID: 23440959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.